Abstract
Two stereoselective parallel divergent four-step procedures to obtain all four enantiomeric forms of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide were developed. Enantiomeric purity was determined by quantitative (1)H NMR spectroscopy in the presence of the chiral shift reagent (+)-MTPA. The biological profile of the obtained compounds was evaluated at all muscarinic receptor subtypes by binding and functional assays.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
CHO Cells
-
Cricetinae
-
Cricetulus
-
Dioxanes / chemical synthesis
-
Dioxanes / chemistry
-
Dioxanes / pharmacology*
-
Humans
-
Magnetic Resonance Spectroscopy
-
Muscarinic Agonists / chemical synthesis*
-
Muscarinic Agonists / chemistry
-
Muscarinic Agonists / pharmacology*
-
Rabbits
-
Stereoisomerism
-
Structure-Activity Relationship
Substances
-
Dioxanes
-
Muscarinic Agonists
-
N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide